BioLife Solutions Inc (NASDAQ:BLFS) major shareholder Casdin Partners Master Fund, L acquired 20,000 shares of BioLife Solutions stock in a transaction on Tuesday, November 19th. The shares were bought at an average price of $15.15 per share, for a total transaction of $303,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Shares of NASDAQ:BLFS traded up $0.94 on Thursday, reaching $16.49. 12,047 shares of the company’s stock were exchanged, compared to its average volume of 176,107. The firm has a market capitalization of $311.90 million, a price-to-earnings ratio of 117.14 and a beta of 1.35. BioLife Solutions Inc has a fifty-two week low of $9.15 and a fifty-two week high of $22.44. The business’s 50-day moving average is $16.33 and its two-hundred day moving average is $17.69. The company has a quick ratio of 5.33, a current ratio of 6.49 and a debt-to-equity ratio of 0.01.
Large investors have recently modified their holdings of the business. JPMorgan Chase & Co. acquired a new position in shares of BioLife Solutions in the second quarter worth about $30,000. Alpine Woods Capital Investors LLC acquired a new position in shares of BioLife Solutions in the 2nd quarter valued at approximately $170,000. Morgan Stanley grew its position in shares of BioLife Solutions by 17.5% in the 2nd quarter. Morgan Stanley now owns 11,506 shares of the medical equipment provider’s stock valued at $195,000 after purchasing an additional 1,713 shares during the period. Menta Capital LLC acquired a new position in shares of BioLife Solutions in the 2nd quarter valued at approximately $202,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in shares of BioLife Solutions in the 2nd quarter valued at approximately $283,000. 46.22% of the stock is currently owned by institutional investors.
BioLife Solutions Company Profile
BioLife Solutions, Inc develops, manufactures, and markets grade cell and tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced cell damage and death.
Further Reading: What are the benefits of buying treasury bonds?
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.